Amedisys, Inc. (AMED) Misses Q4 EPS by 4c; Guides FY12
Amedisys, Inc. (NASDAQ: AMED) reported Q4 EPS of $0.25, $0.04 worse than the analyst estimate of $0.29. Revenue for the quarter came in at $370.7 million versus the consensus estimate of $372.07 million.
Amedisys, Inc. sees FY2012 EPS of $0.95-$1.10, versus the consensus of $0.94. Amedisys, Inc. sees FY2012 revenue of $1.475-$1.525 billion, versus the consensus of $1.45 billion.
For earnings history and earnings-related data on Amedisys, Inc. (AMED) click here.
Amedisys, Inc. sees FY2012 EPS of $0.95-$1.10, versus the consensus of $0.94. Amedisys, Inc. sees FY2012 revenue of $1.475-$1.525 billion, versus the consensus of $1.45 billion.
For earnings history and earnings-related data on Amedisys, Inc. (AMED) click here.